ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
14.01
-0.10 (-0.71%)
At close: Nov 15, 2024, 4:00 PM
13.79
-0.22 (-1.57%)
After-hours: Nov 15, 2024, 5:08 PM EST
ARS Pharmaceuticals Employees
As of December 31, 2023, ARS Pharmaceuticals had 26 total employees, including 24 full-time and 2 part-time employees. The number of employees increased by 6 or 30.00% compared to the previous year.
Employees
26
Change (1Y)
6
Growth (1Y)
30.00%
Revenue / Employee
$98,769
Profits / Employee
-$1,888,615
Market Cap
1.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 26 | 6 | 30.00% |
| Dec 31, 2022 | 20 | 11 | 122.22% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| U.S. Physical Therapy | 6,720 |
| Myriad Genetics | 2,700 |
| MiMedx Group | 895 |
| Schrödinger | 867 |
| Intellia Therapeutics | 526 |
| Harrow | 315 |
| Syndax Pharmaceuticals | 184 |
| Day One Biopharmaceuticals | 155 |
SPRY News
- 3 days ago - ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 days ago - ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024 - Benzinga
- 5 days ago - ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States - GlobeNewsWire
- 6 days ago - ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis) - GlobeNewsWire
- 12 days ago - ARS Pharmaceuticals, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 13 days ago - The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations - Accesswire
- 14 days ago - ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire